Dr. Michael Mullan is distinguished face of
biomedical science. He is widely known for his research work for Swedish
mutation present in familial form. He is well known for his developmental work
in therapeutic cures for Alzheimer’s disease. His arrays of interests have
always been neuroscience, drug development, cognitive development, brain health
and neuropsychiatric diseases.
Dr. Mullan acquired his initial education in
1984 from the Royal Free School of Medicine where he was also positioned as the
President of the Royal Free Mental Handicap Society. After graduating, he
practiced as a Surgeon and later on took the position in psychiatry at Friar
Hospital in London. Subsequently to further increase his experience he joined
Middlesex Hospital Medical School where he was positioned as a researcher in
Molecular Genetic Study of Alzheimer’s disease. It was from there that he kept
on developing interest and desire to find a cure for this disease. Dr. Mullan
has also served as an Honorary Clinical Research Registrar at St. Mary’s
Hospital and The National Hospital for Nervous Diseases. In 1992, Dr. Mullan
joined University of South Florida and thus established Roskamp Laboratories.
In 2003, Roskamp Institute relocated to Sarasota, Florida where Dr. Mullan served
as the Director and conducted various researches on Alzheimer’s disease.
Dr. Michael Mullan in association with his
colleague Dr. Fiona Crawford made the discovery of Swedish mutation and let to
find the initial cause of the Alzheimer’sdisease. They together had created the first animal model for Alzheimer’s
disease. His major research works includes investigating the role of beta
amyloid in inflammation and determining the CD40-CD40L signaling pathways
associated with Alzheimer’s disease pathogenesis. He has acquired several
patents to his name and numerous publications.
Serving at directorial positions of various
organizations, he is currently the CEO and Chairman of the Board of Rockcreek
Pharmaceuticals. As the founder of Roskamp institute in Sarasota, Florida, Dr.
Mullan’s leadership led to cutting edge development in neuropsychiatric
illnesses. His research work was funded by multiple agencies including the NIH
and the Department of defense.
Dr. Michael Mullan works mainly on Alzheimer’s
disease but he is just not limited till there. He has served for finding cures
in childhood metal illness and disorders like Tourette’s syndrome, Autism, Gulf
war illness, Traumatic Brain Injury and Drug Addiction. His work in the field of biomedical research
is very noticeable. He has served for the betterment of a vast majority of the
community. Most of patients of Alzheimer’s disease are the elderly 60 plus. And
preserving the life experiences is one contribution of his for the nation. Many
patients reminisce about their past and it is very hard to see them with fading
memories. Patients suffering from Alzheimer’s disease face the most traumatic
loss as they keep forgetting their recent past as well as their family and
friends. Dr. Mullan’s work has tremendously contributed towards developing FDA
approved drugs for such patients and new developments are still going on at the
Roskamp institute in Florida.
To successfully cure neuropsychiatric
diseases and promote healthy aging, Dr. Michael Mullan founded the Roskamp Institute
with the same mission and to conduct safe and effective drug therapies. He has
been a successful figure in the biomedical science and is achieving great
heights in his work.
No comments:
Post a Comment